4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-22-017162
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 320,516 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | 2022-03-04 | Grant or award · Employee Stock Option (Right to Buy) | +209,655 | 209,655 | D | ||
| TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | 2022-03-04 | Grant or award · Restricted Stock Units | +110,861 | 110,861 | D | ||
Loading xslF345X03/doc4.xml…